Danaher Corporation $DHR Shares Bought by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management increased its Danaher stake by 220.2% in Q4 to 674,373 shares (about 0.10% of the company) worth roughly $154.38 million.
• Danaher beat Q earnings (EPS $2.23 vs. $2.14) with revenue of $6.84B, up 4.6% year‑over‑year, and raised its quarterly dividend to $0.40 (annualized $1.60, yield 0.8%).
• Analysts maintain a consensus Moderate Buy (18 Buys, 3 Holds) with an average target of $251.35, though several firms recently trimmed price targets (e.g., Wolfe to $230, Evercore to $225).

Robeco Institutional Asset Management B.V. grew its position in Danaher Corporation (NYSE:DHR - Free Report) by 220.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 674,373 shares of the conglomerate's stock after acquiring an additional 463,764 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.10% of Danaher worth $154,377,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of DHR. JPL Wealth Management LLC acquired a new position in shares of Danaher in the third quarter worth about $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher in the third quarter worth about $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher in the third quarter worth about $28,000. Finally, Tripletail Wealth Management LLC acquired a new position in shares of Danaher in the third quarter worth about $31,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company's stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. Wolfe Research decreased their price objective on shares of Danaher from $260.00 to $230.00 and set an "outperform" rating for the company in a research report on Wednesday. KeyCorp reiterated an "overweight" rating on shares of Danaher in a research report on Thursday, January 29th. Robert W. Baird set a $251.00 price objective on shares of Danaher in a research report on Thursday, January 29th. Weiss Ratings reiterated a "hold (c)" rating on shares of Danaher in a research report on Friday, March 27th. Finally, Evercore decreased their price objective on shares of Danaher from $254.00 to $225.00 and set an "outperform" rating for the company in a research report on Monday, April 6th. Eighteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $251.35.

Danaher Stock Down 1.7%

Shares of NYSE DHR opened at $189.69 on Friday. Danaher Corporation has a 12-month low of $178.78 and a 12-month high of $242.80. The stock has a market cap of $134.24 billion, a PE ratio of 37.64, a P/E/G ratio of 2.57 and a beta of 0.95. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The company has a 50-day moving average of $201.03 and a 200 day moving average of $214.48.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to analysts' expectations of $6.79 billion. During the same quarter in the prior year, the company earned $2.14 EPS. Danaher's revenue was up 4.6% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a boost from Danaher's previous quarterly dividend of $0.32. Danaher's dividend payout ratio is currently 31.75%.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.